Skip to main content

Stock Price Forecast

Aug. 15, 2025


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Precipio, Inc. chart...

About the Company

We do not have any company description for Precipio, Inc. at the moment.

Exchange

Nasdaq

$21M

Total Revenue

88

Employees

$22M

Market Capitalization

-1.15

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest News on Precipio, Inc.

Precipio, Inc. (NASDAQ:PRPO) Q2 2025 Earnings Call Transcript

on MSN ago, source: Insider Monkey on MSN.com

Welcome to the Precipio Q2 2025 Shareholder Update Conference Call. [Operator Instructions] Please note that this conference ...

Precipio Reports Improved Earnings Amidst Ongoing Challenges

3d ago, source: None

Precipio ( ($PRPO) ) has released its Q2 earnings. Here is a breakdown of the information Precipio presented to its investors. Precipio, Inc. is a ...

Precipio, Inc. Modifies Warrant Structure to Reduce Share ... - Nasdaq

1mon ago, source: Nasdaq

Precipio, Inc. Modifies Warrant Structure to Reduce Share Dilution and Secure $1.2 Million Cash Inflow July 11, 2025 — 04:41 pm EDT Written by None for Quiver Quantitative -> ...

Precipio Announces its Q2-2025 Financial Results

4d ago, source: None

NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company’s ...

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

4mon ago, source: Seeking Alpha

Precipio, Inc. (NASDAQ:PRPO) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ETCompany ParticipantsIlan Danieli - Chief Executive OfficerConference ...

Precipio, Inc. Reports Positive Adjusted EBITDA and Cash Flow for Q4 ...

5mon ago, source: Nasdaq

Precipio, Inc., a specialty cancer diagnostics company, announced significant financial achievements for the fourth quarter of 2024, including a positive Adjusted EBITDA of $0.4 million and an ...

Precipio Announces Q2-2025 Shareholder Update Call

18d ago, source: Yahoo Finance

NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2025 corporate update call on August 14 th, 2025 at 5 ...

Precipio Inc (TGK.BE) - Yahoo Finance

3mon ago, source: Yahoo Finance

Precipio Announces Q4 and year-end 2024 Shareholder Update Call Conference Call to be held on March 31st, 2025 at 5:00 PM ESTNEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer ...

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority ...

1mon ago, source: Yahoo Finance

NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with its largest warrant holder, amending the ...

Precipio, Inc.: Precipio is requesting Shareholders/Brokers vote today ...

2mon ago, source: Finanznachrichten

NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote ...

Precipio Surges 140%, Breaks Out Of A Falling Wedge Pattern

4y ago, source: Benzinga.com

Precipio Inc. (NASDAQ: PRPO) shares surged 140% Monday after the company successfully launched its COVID-19 rapid antibody test that tests for both IgG & IgM antibodies. Testing for antibodies ...

Similar Companies
Company Ticker 90 Days Forecast Market Cap. (USD M) P/E P/B
AGILENT TECHNOLOGIES, INC. A Predict 34091.20 29.24 5.56
Akoya Biosciences, Inc. AKYA Predict 64.34 -2.14 -10.93
ASTROTECH Corp ASTC Predict 8.52 28.87 0.34
Avantor, Inc. AVTR Predict 8818.26 12.83 1.40
Accelerate Diagnostics, Inc AXDX Predict 0.18 -0.21 0.00
BIO-RAD LABORATORIES, INC. BIO Predict 7856.93 24.62 1.10
BIO-RAD LABORATORIES, INC. BIO-B Predict 6815.86 21.36 0.96
Bionano Genomics, Inc. BNGO Predict 11.88 -0.04 0.26
BRUKER CORP BRKR Predict 6144.61 28.33 3.18
Cytek Biosciences, Inc. CTKB Predict 511.81 82.00 1.36
EyePoint Pharmaceuticals, Inc. EYPT Predict 763.99 -4.43 3.11
HARVARD BIOSCIENCE INC HBIO Predict 23.60 -8.33 1.50
ILLUMINA, INC. ILMN Predict 15817.38 12.58 7.00
STANDARD BIOTOOLS INC. LAB Predict 469.48 -2.36 1.11
Lifeloc Technologies, Inc LCTC Predict 8.95 None 1.52
METTLER TOLEDO INTERNATIONAL INC/ MTD Predict 24912.94 31.51 -136.90
Nautilus Biotechnology, Inc. NAUT Predict 90.06 -3.78 0.50
Singular Genomics Systems, Inc. OMIC Predict 50.26 -1.71 0.41
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB Predict 393.46 -1.52 6.40
Precipio, Inc. PRPO Predict 21.94 -1.15 0.62
Quanterix Corp QTRX Predict 208.51 -11.12 0.66
RAPID MICRO BIOSYSTEMS, INC. RPID Predict 116.12 -0.87 2.13
REVVITY, INC. RVTY Predict 10792.11 37.84 1.43
Seer, Inc. SEER Predict 131.32 -1.95 0.38
10x Genomics, Inc. TXG Predict 1660.09 -8.57 2.15
WATERS CORP /DE/ WAT Predict 17401.45 26.31 8.06

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...